Related Experiment Video
Updated: Jun 20, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
An outpatient-based clinical program for type 2 diabetes prevention.
Sophie Bersoux1, Kara L Asbury, Curtiss B Cook
1Division of Community Internal Medicine, Mayo Clinic, Scottsdale, Arizona 85259, USA. bersoux.sophie@mayo.edu
Summary
A clinic-based type 2 diabetes prevention program showed positive results in its first year. Patients with prediabetes experienced weight loss and improved glucose levels, indicating feasibility for outpatient diabetes prevention.
Area of Science:
- Endocrinology
- Preventive Medicine
- Clinical Research
Background:
- Type 2 diabetes is a growing public health concern.
- Prediabetes is a critical stage for intervention.
- Outpatient programs offer accessible avenues for diabetes prevention.
Purpose of the Study:
- To evaluate the initial outcomes of a clinic-based type 2 diabetes prevention program.
- To assess the feasibility and effectiveness of lifestyle interventions for prediabetes management.
Main Methods:
- A cohort of 92 patients with prediabetes participated in the Diet-Exercise-Activity-Lifestyle program.
- Interventions focused on lifestyle modifications.
- Physical therapy assessments identified common physical impairments.
- Changes in weight and glucose tolerance were measured at 6 months.
Main Results:
- 72% of participants achieved weight loss at 6 months.
- Improved fasting glucose and 2-hour glucose tolerance test results were observed.
- High patient satisfaction reported, with 78% rating the program as "very good" or "excellent."
Conclusions:
- Outpatient type 2 diabetes prevention programs are feasible.
- Lifestyle interventions can lead to significant improvements in weight and glucose control.
- Healthcare systems should expand experience with outpatient diabetes prevention strategies to address rising prediabetes prevalence.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...